L&S, ELP on Samara Capital’s 150 crore investment in medical device maker SMT

Gujarat-based manufacturer of medical equipment Sahajanand Medical Technologies (SMT) has raised Rs. 150 crore from Samara Capital Partners.

Deal Samara Capital Partners invests in SMT
Value  150 crore
Deal Type Private Equity
Sector Medical Devices
Law Firms Lakshmikumaran & Sridharan – SMT; Economic Laws Practice – Samara Capital
Partners/Heads Lakshmikumaran & Sridharan – Sudish Sharma; Economic Laws Practice – Darshan Upadhyay

Lakshmikumaran & Sridharan acted for SMT, through a team led by Executive Partner Sudish Sharma, Principal Associate Vatsal Gaur, and Associate Aman Parnami.

Economic Laws Practice represented Samara Capital on the deal, with a team led by Partner Darshan Upadhyay, Joint Partner Amit Manubarwala and Associate Dhairal Shah.

SMT is a leading manufacturer of coronary stents. Market reports estimate India’s coronary stent market to reach nearly USD 531 million in revenues by end of 2016 and grow rapidly at 14% CAGR.

This investment shall boost SMT’s R&D efforts at offering cutting-edge cardiovascular medical devices and facilitating SMT’s entry into competitive global markets, including US, Western Europe and Japan.